Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry L Messmore

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 10, 2008
The immunogenic potential of generic version of low-molecular-weight heparins may not be the same as the branded productsJawed Fareed, Rodger L Bick, Gundu Rao, et al.
Thrombosis Research|April 18, 2002
Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgGBrian Untch, Sarfraz Ahmad, Walter P Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 21, 2008
Contaminant in the recalled unfractionated heparin preparations: where is the problem?Debra A Hoppensteadt, Rakesh Wahi, Cafer Adiguzel, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2002
Reference intervals of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisitedRolandas Gerbutavicius, Jawed Fareed, Harry L Messmore, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 7, 2002
Reference ranges of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisitedRolandas Gerbutavicius, Jawed Fareed, Harry L Messmore, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2010
Simple scoring system for early management of heparin-induced thrombocytopeniaHarry L Messmore, Nancy Fabbrini, Mary L Bird, et al.
Thrombosis Research|February 15, 2003
Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodiesSarfraz Ahmad, Sylvia Haas, Debra A Hoppensteadt, et al.
The Annals of Thoracic Surgery|March 31, 2005
The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary)Victor A Ferraris, Suellen P Ferraris, David J Moliterno, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 10, 2008
The immunogenic potential of generic version of low-molecular-weight heparins may not be the same as the branded productsJawed Fareed, Rodger L Bick, Gundu Rao, et al.
Thrombosis Research|April 18, 2002
Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgGBrian Untch, Sarfraz Ahmad, Walter P Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 21, 2008
Contaminant in the recalled unfractionated heparin preparations: where is the problem?Debra A Hoppensteadt, Rakesh Wahi, Cafer Adiguzel, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2002
Reference intervals of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisitedRolandas Gerbutavicius, Jawed Fareed, Harry L Messmore, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 7, 2002
Reference ranges of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisitedRolandas Gerbutavicius, Jawed Fareed, Harry L Messmore, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2010
Simple scoring system for early management of heparin-induced thrombocytopeniaHarry L Messmore, Nancy Fabbrini, Mary L Bird, et al.
Thrombosis Research|February 15, 2003
Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodiesSarfraz Ahmad, Sylvia Haas, Debra A Hoppensteadt, et al.
The Annals of Thoracic Surgery|March 31, 2005
The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary)Victor A Ferraris, Suellen P Ferraris, David J Moliterno, et al.
Pageof 3